Agile Therapeutics reported $823K in Interest Expense on Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
JAZZ PHA JAZZ:US USD 83.74M 19.86M
Pacira Pharmaceuticals PCRX:US USD 9.86M 1.02M
Pfizer PFE:US USD 311M 18M
Teva Pharmaceutical Industries TEVA:US USD 230M 5M
Therapeuticsmd TXMD:US USD 4.83M 6.86M